Definitions
Sorry, no definitions found. You may find more data at omapro.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Omapro.
Examples
-
Cephalon said yesterday it plans to buy ChemGenex Pharmaceuticals Limited, an Australian company developing a treatment for chronic myeloid leukemia called Omapro, in a deal valued at about $231 million.
-
The drugmaker submitted data on how well the injectable drug, called Omapro, worked in just 66 patients although plans for the study had called for 100 enrollees, U.S.
-
The drugmaker submitted data on how well the injectable drug, called Omapro, worked in just 66 patients although plans for the study had called for 100 enrollees, U.S.
-
The drugmaker submitted data on how well the injectable drug, called Omapro, worked in just 66 patients although plans for the study had called for 100 enrollees, U.S.
-
The drugmaker submitted data on how well the injectable drug, called Omapro, worked in just 66 patients although plans for the study had called for 100 enrollees, U.S.
-
Cephalon also has launched a bid worth about 225 million Australian dollars $240 million for Australia's ChemGenex Pharmaceuticals Ltd., a cancer medicine developer whose Omapro chronic myeloid leukemia treatment is in advanced development.
Australian Drug Upstarts Draw Investor Interest Gavin Lower 2011
-
Cephalon also has launched a bid worth about 225 million Australian dollars $240 million for Australia's ChemGenex Pharmaceuticals Ltd., a cancer medicine developer whose Omapro chronic myeloid leukemia treatment is in advanced development.
Australian Drug Upstarts Draw Investor Interest Gavin Lower 2011
-
(ODAC), which on March 22 recommended that a test to identify the T315I mutation be reviewed by the FDA prior to approving Omapro.
GEN News Highlights 2010
-
The complete response letter asks for the development of a molecular diagnostic but does not request a new study nor the enrollment of additional patients into the pivotal study on Omapro, ChemGenex states.
GEN News Highlights 2010
-
ChemGenex Pharmaceuticals a complete response letter regarding its NDA for Omapro ™ for the treatment of adults with chronic myeloid leukemia (CML) who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation.
GEN News Highlights 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.